Anti-HGFR/c-Met Antibody (Amivantamab)
Catalog No.
F1414
Anti-HGFR/c-Met Antibody (Amivantamab)
Featured Products
Amivantamab (JNJ-61186372) is a humanized EGFR-MET bispecific antibody with immunohistochemical anticancer activity. Amivantamab can inhibit ligand binding, promote endocytosis and degradation of receptor-antibody complexes, and induce Fc-dependent endocytosis of macrophages and antibody-dependent cellular cytotoxicity of natural killer cells.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet
145.88 kDa
Dry ice
2171511-58-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
RYBREVANT, JNJ-61186372
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P08581
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human cMet His at 2 ug/mL can bind Anti-HGFR/c-Met Antibody (Amivantamab)
HGFR / c-Met
Please avoid freeze-thaw cycles.